Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wallach

Showing results (311-320 of 457) with videos related to

Pageof 46
Sort By:
Lymphokine and Cytokine Research|June 1, 1992
Variation in serum levels of the soluble TNF receptors among healthy individualsD Aderka, H Engelmann, Y Shemer-Avni, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1985
[Congenital corporal hemihypertrophy with hypertrichosis]D Wallach, D Jayle, M D Vignon-Pennamen, et al.
The Journal of Biological Chemistry|June 10, 1978
Filamin-actin interaction. Dissociation of binding from gelation by Ca2+-activated proteolysisP J Davies, D Wallach, M C Willingham, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1988
[Synovialosarcoma]M D Vignon-Pennamen, D Wallach, O Verola, et al.
BMC Medicine|June 18, 2019
Postmarketing commitments for novel drugs and biologics approved by the US Food and Drug Administration: a cross-sectional analysisJoshua D Wallach, Anita T Luxkaranayagam, Sanket S Dhruva, et al.
Journal of Reproductive Immunology|July 1, 1995
Soluble tumor necrosis factor receptors and soluble interleukin-6 receptor in fetal and maternal sera, coelomic and amniotic fluids in normal and pre-eclamptic pregnanciesS L Opsjøn, D Novick, N C Wathen, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1989
[Multiple eruptive keratoacanthoma disclosing lymphoma]P P Cabotin, M D Vignon-Pennamen, J M Miclea, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1986
M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosyP Shankar, F Agis, D Wallach, et al.
JAMA Network Open|May 11, 2019
Analysis of Postapproval Clinical Trials of Therapeutics Approved by the US Food and Drug Administration Without Clinical Postmarketing Requirements or CommitmentsJoshua J Skydel, Anita T Luxkaranayagam, Sanket S Dhruva, et al.
JAMA Internal Medicine|November 23, 2020
Characteristics and Reporting of Number Needed to Treat, Number Needed to Harm, and Absolute Risk Reduction in Controlled Clinical Trials, 2001-2019Marissa H Elliott, Joshua J Skydel, Sanket S Dhruva, et al.
Pageof 46

Showing results (311-320 of 457) with videos related to

Sort By:
Pageof 46
Lymphokine and Cytokine Research|June 1, 1992
Variation in serum levels of the soluble TNF receptors among healthy individualsD Aderka, H Engelmann, Y Shemer-Avni, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1985
[Congenital corporal hemihypertrophy with hypertrichosis]D Wallach, D Jayle, M D Vignon-Pennamen, et al.
The Journal of Biological Chemistry|June 10, 1978
Filamin-actin interaction. Dissociation of binding from gelation by Ca2+-activated proteolysisP J Davies, D Wallach, M C Willingham, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1988
[Synovialosarcoma]M D Vignon-Pennamen, D Wallach, O Verola, et al.
BMC Medicine|June 18, 2019
Postmarketing commitments for novel drugs and biologics approved by the US Food and Drug Administration: a cross-sectional analysisJoshua D Wallach, Anita T Luxkaranayagam, Sanket S Dhruva, et al.
Journal of Reproductive Immunology|July 1, 1995
Soluble tumor necrosis factor receptors and soluble interleukin-6 receptor in fetal and maternal sera, coelomic and amniotic fluids in normal and pre-eclamptic pregnanciesS L Opsjøn, D Novick, N C Wathen, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1989
[Multiple eruptive keratoacanthoma disclosing lymphoma]P P Cabotin, M D Vignon-Pennamen, J M Miclea, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1986
M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosyP Shankar, F Agis, D Wallach, et al.
JAMA Network Open|May 11, 2019
Analysis of Postapproval Clinical Trials of Therapeutics Approved by the US Food and Drug Administration Without Clinical Postmarketing Requirements or CommitmentsJoshua J Skydel, Anita T Luxkaranayagam, Sanket S Dhruva, et al.
JAMA Internal Medicine|November 23, 2020
Characteristics and Reporting of Number Needed to Treat, Number Needed to Harm, and Absolute Risk Reduction in Controlled Clinical Trials, 2001-2019Marissa H Elliott, Joshua J Skydel, Sanket S Dhruva, et al.
Pageof 46